CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (25,735)	$ (2,217)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation	1,934	1,224
Amortization of identifiable intangibles assets	717	261
Stock-based compensation	164	109
Deferred income taxes	(13,879)	(1,111)
Other-than-temporary impairment on investments, available-for-sale	147
Net realized (gains) losses on sales and redemptions of investments	(4,880)	13
Investment income from other investments	(408)	(301)
Gain on sale of foreclosed real estate, net	(1,237)
Other	170	212
Change in:
Premiums, fees, and commission receivable	(5,886)	(18,041)
Deferred acquisition costs	(241)	(1,969)
Loss and loss adjustment expense reserves	42,629	18,396
Unearned premiums and fees	6,394	18,935
Accrued expenses	(47)	6,122
Other liabilities	(4,913)	2,403
Other	(692)	13
Net cash (used in) provided by operating activities	(5,763)	24,049
Cash flows from investing activities:
Purchases of investments, available-for-sale	(62,950)	(21,022)
Maturities and redemptions of investments, available-for-sale	9,155	8,372
Sales of fixed maturities, available-for-sale	66,879
Purchases of other investments	(957)	(1,739)
Distributions from other investments	3,270	577
Net change in receivable/payable for securities	17,903
Capital expenditures	(1,523)	(1,529)
Proceeds from sale of foreclosed real estate, net	1,769
Acquisition of identifiable intangible assets	(40)	(205)
Business acquired through asset purchase		(33,770)
Net cash provided by (used in) investing activities	33,506	(49,316)
Cash flows from financing activities:
Proceeds from term loan from principal stockholder		30,000
Net proceeds from issuance of common stock	41	45
Net cash provided by financing activities	41	30,045
Net change in cash, cash equivalents, and restricted cash	27,784	4,778
Cash, cash equivalents, and restricted cash, beginning of period	115,587	102,429
Cash, cash equivalents, and restricted cash, end of period	$ 143,371	$ 107,207